🔗 Visit the ClinicalTrials.gov page for NCT01881789
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Clinical use of proteasome inhibitors in the treatment of multiple myeloma. | Pharmaceuticals (Basel) | 2014 | 0.91 |
2 | Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity. | Bone Marrow Transplant | 2016 | 0.82 |
3 | Salvage therapies in relapsed and/or refractory myeloma: what is current and what is the future? | Onco Targets Ther | 2016 | 0.76 |
4 | Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities. | J Mol Med (Berl) | 2015 | 0.75 |
5 | Trial Watch: Proteasomal inhibitors for anticancer therapy. | Mol Cell Oncol | 2014 | 0.75 |